# It's official: anyone can now invest in Sempresto. | Sempresto

- Canonical URL: https://wefunder.com/feed/382730
- Entity ID: wefunder:feed_item:382730
- Published at: 2026-09-09 17:54:00 UTC
- Updated at: 2026-09-09 17:54:00 UTC

## Author
Elizabeth Reczek

## Subject
Sempresto

## Content
Sempresto's community round is now open to the public! For the first time, anyone, not just accredited investors, can own a stake in the next generation of anaphylaxis response.Here's where we stand currently:💰 Over $4M committed, including a lead investment from Dominic Frederico and a strategic partnership with Thomas Jefferson University🔬 15 patents granted, 10 pending, across our phone-based platform🏥 FDA filing targeted within 18 months, no clinical trials required📱 Companion app and 24/7 telehealth built in, targeting a 2028 launch🎯 $3B+ addressable market; 33 million Americans living with food allergies👥 Team behind 3 IPOs and 30+ business development transactionsEpinephrine delivery hasn't meaningfully changed in decades. People still die from anaphylaxis every year because the medication that could have saved them wasn't with them. We built Sempresto to fix that, beginning with a phone-based device people will actually carry.Today, we invite the people who live this every day: allergy patients, the families who protect them, the clinicians who treat them, and anyone who believes this problem deserves a real fix. We'd love to have you on board.Invest today → wefunder.com/sempresto Let's equip every allergy family with the tools they deserve.Elizabeth Reczek, PhDCo-Founder & CEO, Sempresto